GB:0RN3's free cash flow for Q4 2022 was ¥―. For the 2022 fiscal year, GB:0RN3's free cash flow was decreased by ¥-590.82B and operating cash flow was ¥―. See a summary of the company’s cash flow.

Cash Flow	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Operating Cash Flow	¥ 683.46B	¥ 805.71B	¥ 948.02B	¥ 1.01T	¥ 669.75B	¥ 328.48B
Investing Cash Flow	¥ -168.61B	¥ -607.10B	¥ -198.13B	¥ 393.53B	¥ 292.12B	¥ -2.84T
Financing Cash Flow	¥ -702.55B	¥ -602.36B	¥ -927.36B	¥ -1.09T	¥ -1.01T	¥ 2.95T
Cash Flow From Discontinued Operation	-	-	-	-	¥ 0.00	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	¥ 2.13T	¥ 445.94B	¥ 788.76B	¥ 966.22B	¥ 637.61B	¥ 702.09B
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	-	-	-	-	-	-
Issuance Of Debt	-	¥ -325.07B	¥ -600.48B	¥ 1.18T	¥ 496.19B	¥ 2.80T
Repayment Of Debt	¥ -314.10B	¥ -400.07B	¥ -849.81B	¥ -1.69T	¥ -731.06B	¥ -1.74B
Free Cash Flow	¥ 493.85B	¥ 172.98B	¥ 763.80B	¥ 774.46B	¥ 452.04B	¥ 194.37B
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in JPY

Takeda Pharmaceutical Co Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing